Mar 09, 2023 / 12:30PM GMT
Operator
Good day, ladies and gentlemen, and welcome to Clene's HEALEY ALS Platform Trial data update conference call. At this time, all participants are in a listen-only mode. Later, we will conduct a question and answer session and instructions to follow at that time. As a reminder, this call may be recorded. I would now like to introduce your host for today's conference, Rob Etherington. You may begin.
Rob Etherington - Clene Inc. - President and CEO
Thank you, operator. Good morning, everybody. Thank you for joining, and certainly we're very pleased to talk to you this morning about new data we've released this morning from the HEALEY ALS Platform Trial regarding our regimen, regimen CNM-Au8.
During the course of this call, we will be making a number of forward-looking statements and as is typically understood in such forward looking statement conversations, we are under no obligation to necessarily update these, and we're thankful for your time and attention. Over the course of the next few minutes, I'll do a brief, very brief introduction, and we will
Clene Inc. To Discuss Healey ALS Platform Trial Data Update Call Transcript
Feb 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers